Patterns of Prescribing and Monitoring of Palbociclib

NCT03285568 · clinicaltrials.gov ↗

COMPLETED

Status

67

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer
Advanced Breast Cancer
Estrogen Receptor-positive Breast Cancer
Human Epidermal Growth Factor 2 Negative Carcinoma of Breast

Interventions

DRUG: Palbociclib

Sponsor

Rush University Medical Center